Form 4 for IRMD IRADIMED CORP
Accepted 2023-12-05 00:00:00 ET · period of report 2023-12-01 · accession 0001415889-23-015865 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-12-05 | 2023-12-01+ | IRMD | HAWKINS JAMES B | Dir | S - Sale | $43.02 | -9,532 | 36.6K | -21% | -$410.1K |
| DM | 2023-12-05 | 2023-12-01+ | IRMD | HAWKINS JAMES B | Dir | A - Grant | $7.10 | +9,532 | 41.8K | +30% | +$67.7K |
| DM | 2023-12-05 | 2023-12-01+ | IRMD | HAWKINS JAMES B | Dir | M - OptEx | $0.00 | -9,532 | 4,741 | -67% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-04 | S | D | 4,273 | $42.70 | 36,562 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $42.70 to $42.78. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2023-12-04 | A | A | 4,273 | $7.10 | 40,835 | D | — | — | (F1) This option, representing a right to purchase a total of 10,000 shares, was granted on 9-29-2014 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. |
| 3 | Common | Common Stock | 2023-12-01 | S | D | 5,259 | $43.28 | 36,562 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $42.70 to $43.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2023-12-01 | A | A | 5,259 | $7.10 | 41,821 | D | — | — | (F1) This option, representing a right to purchase a total of 10,000 shares, was granted on 9-29-2014 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. |
| 5 | Derivative | Stock Options (Right to Buy) | 2023-12-04 | M | D | 4,273 | $0.00 | 468 | D | $7.10 · — to 2024-09-29 | 4,273 Common Stock | (F1) This option, representing a right to purchase a total of 10,000 shares, was granted on 9-29-2014 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. |
| 6 | Derivative | Stock Options (Right to Buy) | 2023-12-01 | M | D | 5,259 | $0.00 | 4,741 | D | $7.10 · — to 2024-09-29 | 5,259 Common Stock | (F1) This option, representing a right to purchase a total of 10,000 shares, was granted on 9-29-2014 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. |